Position in NVS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$120,672
+$20,027 QoQ
Shares Held
790
+8.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Annis Gardner Whiting Capital Advisors, LLC holds $18,574,820 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
19,005 | $4,826,699 | |
| 2 | AMGN |
Amgen Inc
|
7,897 | $2,859,661 | |
| 3 | NVO |
Novo Nordisk A S
|
58,858 | $2,821,652 | |
| 4 | LLY |
ELI LILLY & Co
|
1,713 | $2,054,623 | |
| 5 | ABBV |
AbbVie Inc.
|
6,840 | $1,721,217 | |
| 6 | PFE |
Pfizer Inc
|
61,427 | $1,479,162 | |
| 7 | BIIB |
Biogen Inc.
|
5,233 | $1,130,641 | |
| 8 | MRK |
Merck & Co., Inc.
|
8,338 | $1,071,433 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $120,672 | 790 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $100,645 | 730 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $45,396 | 354 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $57,600 | 476 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $40,132 | 360 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $36,880 | 379 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $43,592 | 379 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $40,348 | 379 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $36,660 | 379 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $38,772 | 384 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $39,114 | 384 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||